"Trade what you see not what you think" Bullish Sentiment

Interest in this market

ABBV stock- Strong area of support that rallied up to the 125s which clearly shows institutional interest within the 94-98 zone.

1-3 risk to reward whilst still keeping an eye on 85s

Reason for opposing catalyst
Retail Investors had all the there chips in hoping for accelerated approval for the drug Rova-T (Drug) which they forked out just shy of $6 billion for Stemcentrx, (Defeating the purpose of the acquisition)

Risk management
Cut losses quickly
Wait till price action breaches more into the level to buy cheaper
priceactionStocksTrend Analysis

Exención de responsabilidad